USFDA concludes inspection at Andhra Pradesh facility of Aurobindo Pharma’s arm

05 Apr 2024 Evaluate

The United States Food and Drug Administration (USFDA) has concluded the inspection at Aurobindo Pharma’s stepdown subsidiary -- Eugia Steriles’ new injectable facility situated at Parawada Mandal, Anakapalli District, Andhra Pradesh. 

USFDA had conducted an inspection from March 28, 2024 to April 05, 2024. The inspection closed with 3 observations. The observations are procedural in nature and will be responded to within the stipulated time.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1186.00 -1.20 (-0.10%)
31-Dec-2025 12:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1718.70
Dr. Reddys Lab 1269.00
Cipla 1501.20
Zydus Lifesciences 913.50
Lupin 2104.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×